cell therapy

2026 year ahead look ahead preview forecast new year
Pharma

3 biopharma CEOs explain why they are 'authentically optimistic'

That was the consensus among leaders from three biopharma companies—Perspective, Lineage and Catalyst—who sat down with Fierce late last year.
Fraiser Kansteiner Jan 6, 2026 11:54am
two green lights

FDA signs off on expansion for Gamida Cell's Omisirge

Dec 9, 2025 8:19am
Alert

FDA warns of intestinal disorder risk with use of J&J's Carvykti

Oct 13, 2025 11:16am
ocean covering up money lost investment
Favicon Fierce Biotech

Novo ends all cell therapy R&D, lets go of staff

Oct 10, 2025 3:30pm
An artists 3D rendering of cancerous blood cells among healthy red blood cells The cells fill the image and are of various

ExCellThera's blood cancer cell therapy Zemcelpro earns EU nod

Aug 27, 2025 7:40am
embryonic stem cells
Favicon Fierce Biotech

Cell therapy biotech keeps adapting, selling 4 programs for $55M

Jul 28, 2025 10:52am